Sign In
Samples
/
Jaypirca
Oncology
Jaypirca
pirtobrutinib
Manufacturer
Eli Lilly
Indication
BTK inhibitor for relapsed/refractory mantle cell lymphoma and CLL/SLL
Restrictions:
Oncology specialty required
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with Eli Lilly
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from Eli Lilly
View all
Mounjaro
tirzepatide
Diabetes
Zepbound
tirzepatide
Obesity
Jardiance
empagliflozin
Diabetes
Trulicity
dulaglutide
Diabetes
Taltz
ixekizumab
Immunology
Verzenio
abemaciclib
Oncology
More Oncology Samples
View all
Keytruda
pembrolizumab
Merck
Tecentriq
atezolizumab
Genentech (Roche)
Darzalex
daratumumab
Janssen (J&J)
Tagrisso
osimertinib
AstraZeneca
Herceptin
trastuzumab
Genentech (Roche)
Ibrance
palbociclib
Pfizer
Popular Samples
Browse all
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Eliquis
apixaban
Pfizer
Cardiovascular
Dupixent
dupilumab
Sanofi
Immunology
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas
Jaypirca (pirtobrutinib) Drug Samples | PrescriberPoint | PrescriberPoint